Genfit S.A.
DelistedCIK 1757064fmd_1E7727H2W8C44FT8DRAEEGJNNPManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2017 to Dec 31, 2024, 11 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 7 | 7 | 41 | 8 | 86 | 27 | 38 | 71 |
| Research and development | 54 | 67 | 66 | 59 | 35 | 36 | 47 | 47 |
| Selling, general and administrative | – | 10 | 31 | 25 | 18 | 17 | 19 | 20 |
| Operating income | (57) | (69) | (58) | (83) | 32 | (27) | (27) | 3 |
| Interest expense | 3 | 11 | 13 | 25 | 7 | 5 | 6 | 5 |
| Income before taxes | (59) | (80) | (66) | (102) | 69 | (24) | (29) | 2 |
| Income tax expense | (3) | (0) | (1) | (0) | 2 | (0) | 0 | 0 |
| Net income from continuing operations | (56) | (80) | (65) | (101) | 67 | (24) | (29) | 2 |
| Net income | (56) | (80) | (65) | (101) | 67 | (24) | (29) | 2 |